Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Fulgent Genetics

NASDAQ FLGT
$22.50 -0.07 -0.31%
Today share price
USA
Sector: Healthcare Industry: Health Care Providers & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 23 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

669.80M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
580.98M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.49
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
29.77M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-22.17 %

Upcoming events Fulgent Genetics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Fulgent Genetics

Stock analysis Fulgent Genetics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-4.04 15.68
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.59 2.61
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-12.54 12.57
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
1.92 1.09
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-14.69 3.65

Price change Fulgent Genetics per year

30.05$ 189.89$
Min Max

Summary analysis Fulgent Genetics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Fulgent Genetics

Revenue and net income Fulgent Genetics

All parameters

Stock news Fulgent Genetics

All news
4 August 2023 в 14:40

Fulgent Genetics Shares Rise on Higher Outlook, Strong 2Q Results

4 August 2023 в 14:40

Fulgent Genetics Shares Rise on Higher Outlook, Strong 2Q Results

18 November 2022 в 15:30

Fulgent Genetics started at outperform with $45 stock price target at Raymond James

5 November 2019 в 16:47

ЛИДЕРЫ УОЛЛ-СТРИТ-Chegg, FlexShopper, EverQuote, Fulgent Genetics

About company Fulgent Genetics

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home COVID-19 test capabilities; and has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Address:
4978 Santa Anita Avenue, Temple City, CA, United States, 91780
Company name: Fulgent Genetics
Issuer ticker: FLGT
ISIN: US3596641098
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2016-09-29
Sector: Healthcare
Industry: Health Care Providers & Services
Site: https://www.fulgentgenetics.com

On which stock exchange are Fulgent Genetics (FLGT) stocks traded?

Fulgent Genetics (FLGT) stocks are traded on NASDAQ.

What is the ticker of Fulgent Genetics stocks (FLGT)?

The stock ticker of Fulgent Genetics’s stocks or in other words, the code is FLGT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Fulgent Genetics (FLGT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Fulgent Genetics (FLGT) belongs to the «Healthcare» sector and the «Health Care Providers & Services» industry.

In what currency are Fulgent Genetics (FLGT) stocks traded?

Fulgent Genetics (FLGT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Fulgent Genetics (FLGT) stocks today?

The current price of Fulgent Genetics stocks on 17.05.2024 is 22.5 dollars. per share.

What is the dynamics of Fulgent Genetics (FLGT) stocks from the beginning of the year?

Fulgent Genetics (FLGT) quotes have increased by -23.18% from the beginning of the year up to 22.5 dollars. per 1 stocks.

How much did Fulgent Genetics (FLGT) stocks increase in мае 2024?

This month Fulgent Genetics (FLGT) quotes have increased by 8.7% to 22.5 dollars. per share.

How much are Fulgent Genetics (FLGT) stocks worth?

Today, on October, 17.05.2024 Fulgent Genetics’s (FLGT) stocks cost 22.5 dollars..

What is the market capitalization of Fulgent Genetics (FLGT)?

Capitalization is the market value of Fulgent Genetics (FLGT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 17.05.2024, the market capitalization of Fulgent Genetics (FLGT) is estimated at about 669802500 dollars.